Girl with lens

MiSight® 1 day

MiSight® 1 day


  • MiSight® 1 day covers nearly 100% of spherical prescriptions for age-appropriate children with myopia
  • Easy to fit, single use lens
  • Corrects refractive error and slows the elongation of the eye through ActivControl Technology
  • Suitable for age-appropriate children*
MiSight Box Plastic Neutral Certification

The MiSight® 1 day lens is clinically proven to slow the progression of myopia in age-appropriate children.2* 

The efficacy of MiSight® 1 day was validated in a multi-year clinical study that enrolled children between 8 and 12 years old. The MiSight® 1 day clinical study is the longest continuous soft contact lens study for myopia management.

How MiSight® 1 day contact lenses work

MiSight® 1 day with ActivControl Technology helps slow the elongation of the eye and reduces myopia progression, while fully correcting refractive error.2 Addressing axial elongation helps to reduce the risk of myopia-related vision complications later in life, including irreversible vision loss.3

How lenses work

Two treatment zones create myopic defocus with image focus in front of the retina, rather than behind it to slow axial elongation. 

Two correction zones correct myopia in all gaze positions.

Watch stories of how MiSight® 1 day has helped make a difference in patients’ lives PATIENT STORIES

Girl reading

Watch stories of how MiSight® 1 day has helped make a difference in patients’ lives PATIENT STORIES

Clinical Study

Part 1

Over three years, MiSight® 1 day reduced the rate of myopia progression by 59% on average, compared to a single vision 1-day lens.2


Change in Spherical Equivalent Refractive Error (SERE)

With MiSight® 1 day, over a three year period, there was also a 52% average reduction in axial lengthening, compared to a single vision 1-day lens.2


Change in axial length

Part 2

In Part 2 (years 4 to 6) of the MiSight® 1 day clinical study, children in the control group wearing Proclear® 1 day were switched into MiSight® 1 day. 

New and established MiSight® 1 day wearers had comparable rates of myopic progression and axial length growth.4 Children†† adapted to spherical contact lenses achieved excellent visual acuity when they switched to MiSight® 1 day.4 

The clinical study of MiSight® 1 day lenses was the first to demonstrate sustained slowing of eye growth with a soft contact lens over time.5†

Part 3

In the seventh year of the MiSight® 1 day clinical study, treatment was discontinued for all participants. Data indicated that there was no rebound effect with MiSight® 1 day contact lenses.6,7±


Peer-Reviewed Papers

The MiSight® 1 day clinical study findings have been published in Optometry and Vision Science, the peer review journal of the American Academy of Optometry. 

A new peer-reviewed paper has further validated the myopia control efficacy of CooperVision’s innovative MiSight® 1 day contact lenses. Published in Ophthalmic and Physiological Optics, the journal of the UK College of Optometrists, Six-Year Cumulative Treatment Effect and Treatment Efficacy of a Dual Focus Myopia Control Contact Lens (Chamberlain P, et al) details findings and insights from the groundbreaking study—the longest investigation of its kind. 

This new paper joins a growing body of peer-reviewed research stemming from the CooperVision MiSight® 1 day study including Long-Term Effect of Dual-FocusContact Lenses on Myopia Progression in Children: A 6-year Multicenter Clinical Trial (Chamberlain P, et al.), Ocular Health of Children Wearing Daily Disposable Contact Lenses Over a 6-year Period (Woods J, et al.) and Axial Length Targets for Myopia Control (Chamberlain P, et al.), as well as the recent Garland W. Clay Award winner, A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control (Chamberlain P, et al.).

Are you interested in MiSight® 1 day?
Sign up for updates.

Sign up

Boy in class

Eye Care Professionals have access to marketing assets to support you, your practice and staff, pediatric patients with myopia and their parents. 

Check out MiSightPro to see what is available to you.

Learn more


Product Details

Material / H2O content
Omafilcon A / 60%
Replacement schedule
ActivControl Technology
Base curve
Sphere power
-0.50 to -7.00 (0.50D steps after -6.00)
Revenue carton size